SCHEMBL2651171

SCHEMBL2651171

OC[C@H](c1ccc(-c2ccccc2C(F)(F)F)cc1)C1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.43
CNR2 P34972 4/20 0.42
DPP4 P27487 1/20 0.40
DPP7 Q9UHL4 1/20 0.40
SCN9A Q15858 1/20 0.40
SLC13A5 Q86YT5 1/20 0.39
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
FFAR4 Q5NUL3 1/20 0.39
FFAR1 O14842 1/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
USP2 O75604 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2652751 0.81 TRPV3 (0.46) FFAR1CYP3A4MEN1KMT2ATRPV3
SCHEMBL2652705 0.81 TRPV3 (0.46) FFAR1CYP3A4MEN1KMT2ATRPV3
SCHEMBL2269649 0.78 CNR2 (0.48) PTPN1CNR2DPP4DPP7SCN9A
SCHEMBL2269646 0.78 CNR2 (0.48) PTPN1CNR2DPP4DPP7SCN9A
SCHEMBL2269641 0.78 CNR2 (0.48) PTPN1CNR2DPP4DPP7SCN9A
SCHEMBL2654112 0.77 MAOB (0.45) PTPN1FFAR1
SCHEMBL966816 0.76 MEN1 (0.58) FFAR1MEN1KMT2A
SCHEMBL2652638 0.76 TRPV3 (0.46) RXFP1CYP3A4MEN1KMT2ATRPV3
SCHEMBL7428096 0.75 MEN1 (0.55) FFAR1MEN1KMT2AGAA
SCHEMBL21495045 0.72 EPHX2 (0.46) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758859-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005118542-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-15 WO disclosed